{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:58:10Z","timestamp":1774342690954,"version":"3.50.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dyslipidemia may contribute to pathogenesis and disease complications in limited cutaneous systemic sclerosis (lcSSc), while data about its associations with endothelial dysfunction and clinical lcSSc-specific parameters as well as its predictive role on disease complications are limited. This study investigated the relationship between lipid parameters, endothelial dysfunction, and disease complications in patients with lcSSc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>38 patients with lcSSc and 38 matched controls with primary Raynaud\u2019s phenomenon were analyzed at baseline regarding lipid parameters, parameters of endothelial dysfunction and clinical lcSSc-specific parameters. During a subsequent 3-year follow-up period, patients with lcSSc were prospectively observed for disease complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients with lcSSc exhibited lower high-density lipoprotein (HDL) levels (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.032) and total HDL particles (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.001) as well as higher triglyceride levels (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.018), triglycerides\/HDL ratio (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.013) and atherogenic index (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.012) compared to controls. Large low-density lipoprotein (LDL) particles correlated positively with endothelial microparticles (\n                      <jats:italic>r<\/jats:italic>\n                      \u202f=\u202f0.464,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.044), while very low-density lipoprotein size correlated negatively with symmetric dimethylarginine (\n                      <jats:italic>r<\/jats:italic>\n                      \u202f=\u202f\u22120.480,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.033). No significant correlations were observed between lipid parameters and clinical lcSSc-specific parameters. Incidence of macrovascular events and interstitial lung disease were associated with a few selected lipid parameters (all\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with lcSSc showed a more pro-atherogenic lipid profile. Although statistically significant, these results were of modest magnitude and should be interpreted in the context of the exploratory design. Associations with endothelial dysfunction and clinical disease parameters were minimal or non-significant. Selected lipid parameters may be associated with disease complications in lcSSc, but these findings require confirmation in larger, adequately powered studies due to the small sample size and exploratory analyses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1794319","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:25:28Z","timestamp":1774329928000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of lipid parameters with the development of disease complications in patients with limited cutaneous systemic sclerosis: a prospective exploratory cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Leyla","family":"Schweiger","sequence":"first","affiliation":[{"name":"Division of Angiology, Department of Internal Medicine, Medical University of Graz","place":["Graz, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Meinitzer","sequence":"additional","affiliation":[{"name":"Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz","place":["Graz, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heimo","family":"Strohmaier","sequence":"additional","affiliation":[{"name":"Center of Medical Research (ZMF), Medical University of Graz","place":["Graz, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnther","family":"Silbernagel","sequence":"additional","affiliation":[{"name":"Division of Angiology, Department of Internal Medicine, Medical University of Graz","place":["Graz, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentine","family":"Moazedi-F\u00fcrst","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Medical University of Graz","place":["Graz, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoria","family":"Nemecz","sequence":"additional","affiliation":[{"name":"Division of Angiology, Department of Internal Medicine, Medical University of Graz","place":["Graz, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Kurzmann-G\u00fctl","sequence":"additional","affiliation":[{"name":"Division of Angiology, Department of Internal Medicine, Medical University of Graz","place":["Graz, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Brodmann","sequence":"additional","affiliation":[{"name":"Division of Angiology, Department of Internal Medicine, Medical University of Graz","place":["Graz, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Hafner","sequence":"additional","affiliation":[{"name":"Division of Angiology, Department of Internal Medicine, Medical University of Graz","place":["Graz, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Jud","sequence":"additional","affiliation":[{"name":"Division of Angiology, Department of Internal Medicine, Medical University of Graz","place":["Graz, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00296-004-0580-8","article-title":"Lipoprotein profile in limited systemic sclerosis","volume":"25","author":"Borba","year":"2005","journal-title":"Rheumatol Int"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00296-025-05932-1","article-title":"Classic lipid profile and lipoproteina in systemic sclerosis: a systematic review and meta-analysis of case-control studies","volume":"45","author":"Mastori-Kourmpani","year":"2025","journal-title":"Rheumatol Int"},{"key":"ref3","first-page":"629","article-title":"Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations","volume":"32","author":"Kodera","year":"2005","journal-title":"J Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1530909","DOI":"10.3389\/fimmu.2025.1530909","article-title":"Aberrant lipid profiles and lymphocyte counts in systemic sclerosis population, reassessing predictive value for concurrent cardiovascular diseases","volume":"16","author":"Guo","year":"2025","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13075-021-02443-9","article-title":"HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis","volume":"23","author":"Ferraz-Amaro","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/antiox12091668","article-title":"Malondialdehyde serum levels in patients with systemic sclerosis relate to dyslipidemia and low ventricular ejection fraction","volume":"12","author":"Ibrahim-Achi","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"6054","DOI":"10.1111\/febs.70177","article-title":"Multi-omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosis","volume":"292","author":"Bouffette","year":"2025","journal-title":"FEBS J"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3109\/03009741003605648","article-title":"Subclinical atherosclerosis in scleroderma patients","volume":"39","author":"Tsifetaki","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2147\/CLEP.S427881","article-title":"Association between lipid profile and risk of incident systemic sclerosis: a nationwide population-based study","volume":"15","author":"Kwon","year":"2023","journal-title":"Clin Epidemiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.55563\/clinexprheumatol\/243mpp","article-title":"Evaluation of endothelial dysfunction and clinical events in patients with early-stage vasculopathy in limited systemic sclerosis","volume":"39","author":"Jud","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00296-025-05919-y","article-title":"Endothelial function and vascular events in patients with limited cutaneous systemic sclerosis (EFVELSS): a prospective observational study","volume":"45","author":"Jud","year":"2025","journal-title":"Rheumatol Int"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"8806","DOI":"10.3390\/jcm14248806","article-title":"Association of inflammation-based ratios with endothelial dysfunction markers and clinical parameters in limited cutaneous systemic sclerosis","volume":"14","author":"Schweiger","year":"2025","journal-title":"J Clin Med"},{"key":"ref13","first-page":"2386","article-title":"Endothelial and adrenergic dysfunction in Raynaud\u2019s phenomenon and scleroderma","volume":"26","author":"Freedman","year":"1999","journal-title":"J Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3390\/jcm11092490","article-title":"Raynaud's phenomenon with focus on systemic sclerosis","volume":"11","author":"Maciejewska","year":"2022","journal-title":"J Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cca.2018.11.010","article-title":"Phlebotomy tube interference with nuclear magnetic resonance (NMR) lipoprotein subclass analysis","volume":"488","author":"Needham","year":"2019","journal-title":"Clin Chim Acta"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/biomedicines10010193","article-title":"Effects of alirocumab on triglyceride metabolism: a fat-tolerance test and nuclear magnetic resonance spectroscopy study","volume":"10","author":"Metzner","year":"2022","journal-title":"Biomedicine"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1100453","DOI":"10.3389\/fendo.2023.1100453","article-title":"Combination model of neutrophil to high-density lipoprotein ratio and system inflammation response index is more valuable for predicting peripheral arterial disease in type 2 diabetic patients: a cross-sectional study","volume":"14","author":"Song","year":"2023","journal-title":"Front Endocrinol"},{"key":"ref19","first-page":"78","article-title":"Atherogenic indices in stroke patients: a retrospective study","volume":"16","author":"Sujatha","year":"2017","journal-title":"Iran J Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cca.2007.07.006","article-title":"Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method","volume":"384","author":"Meinitzer","year":"2007","journal-title":"Clin Chim Acta"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/eji.201970107","article-title":"Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)","volume":"49","author":"Cossarizza","year":"2019","journal-title":"Eur J Immunol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/art.24394","article-title":"Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients","volume":"61","author":"Sebastiani","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/ard.2007.079756","article-title":"Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients","volume":"67","author":"Sulli","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5301\/jsrd.5000231","article-title":"Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis","volume":"2","author":"Khanna","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/bor.0000434668.32150.e5","article-title":"Measuring response in the gastrointestinal tract in systemic sclerosis","volume":"25","author":"Khanna","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","article-title":"The European scleroderma trials and research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index","volume":"76","author":"Valentini","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force","volume":"39","author":"Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/eurheartj\/ehac605","article-title":"High-density lipoprotein revisited: biological functions and clinical relevance","volume":"44","author":"von Eckardstein","year":"2023","journal-title":"Eur Heart J"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.5551\/jat.RV22042","article-title":"Beyond high-density lipoprotein-cholesterol: Unraveling the complexity of high-density lipoprotein functionality","volume":"32","author":"Endo","year":"2025","journal-title":"J Atheroscler Thromb"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"120574","DOI":"10.1016\/j.cca.2025.120574","article-title":"High-density lipoprotein in cardiovascular diseases: from high quantity to high quality","volume":"578","author":"Zhang","year":"2026","journal-title":"Clin Chim Acta"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1161\/01.cir.96.8.2520","article-title":"Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction","volume":"96","author":"Gaziano","year":"1997","journal-title":"Circulation"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1373\/clinchem.2004.033175","article-title":"Atherogenic index of plasma [log(triglycerides\/HDL-cholesterol)]: theoretical and practical implications","volume":"50","author":"Dobi\u00e1\u0161ov\u00e1","year":"2004","journal-title":"Clin Chem"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"186","DOI":"10.54005\/geneltip.1331223","article-title":"Evaluation of subclinical atherosclerosis in patients with psoriatic arthritis","volume":"34","author":"Atik","year":"2024","journal-title":"Genel T\u0131p Dergisi"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.3390\/ijms24044097","article-title":"Current trends in vascular biomarkers for systemic sclerosis: a narrative review","volume":"24","author":"Fioretto","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.3390\/ijms26062380","article-title":"Characterization of circulating vesicles of complicated and uncomplicated systemic sclerosis patients and their role in vascular dysfunction","volume":"26","author":"Grossini","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1113\/EP086991","article-title":"Attenuated nitric oxide bioavailability in systemic sclerosis: evidence from the novel assessment of passive leg movement","volume":"103","author":"Clifton","year":"2018","journal-title":"Exp Physiol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s10067-022-06472-w","article-title":"The role of asymmetric dimethylarginine in endothelial dysfunction and abnormal nitric oxide metabolism in systemic sclerosis: results from a pilot study","volume":"42","author":"Pagkopoulou","year":"2023","journal-title":"Clin Rheumatol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.46497\/ArchRheumatol.2023.9638","article-title":"Proprotein convertase subtilisin\/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: a marker of disease activity and severe disease manifestations with potential therapeutic implementations","volume":"38","author":"Artin","year":"2022","journal-title":"Arch Rheumatol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/rheumatology\/ken078","article-title":"Macrovascular disease and atherosclerosis in SSc","volume":"47","author":"Hettema","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"18871","DOI":"10.1038\/s41598-025-99139-w","article-title":"Association between triglyceride glucose index and organ involvement in patients with systemic sclerosis","volume":"15","author":"Yang","year":"2025","journal-title":"Sci Rep"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12944-024-02062-8","article-title":"The novel molecular mechanism of pulmonary fibrosis: insight into lipid metabolism from reanalysis of single-cell RNA-seq databases","volume":"23","author":"Shi","year":"2024","journal-title":"Lipids Health Dis"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/art.38288","article-title":"Association of interferon- and transforming growth factor \u03b2-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis","volume":"66","author":"Christmann","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"14287","DOI":"10.3390\/ijms241814287","article-title":"The pathogenesis of systemic sclerosis: the origin of fibrosis and interlink with vasculopathy and autoimmunity","volume":"24","author":"Ko","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3390\/ijms24032963","article-title":"The molecular mechanisms of systemic sclerosis-associated lung fibrosis","volume":"24","author":"Mouawad","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1794319\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:25:29Z","timestamp":1774329929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1794319\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":45,"alternative-id":["10.3389\/fnut.2026.1794319"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1794319","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"article-number":"1794319"}}